Meseclazone (W-2395) also known as 2-methylseclazone is a non-steroidal anti-inflammatory drug (NSAID) developed in the 1970s. It functions as a prodrug to the 5-chloro derivative of salicyclic acid. It was never marketed on account of toxicity issues namely pertaining to the liver.
This page contains content from the copyrighted Wikipedia article "Meseclazone"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
